This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Medical Ethics  • Patient-Physician Communication  • End-of-life Care/ Palliative Medicine  • Congenital Malformations  • Neonatology and Infant Care  • Cardiovascular System  • Surgery  • Pediatric Surgery  • Prognosis/ Outcomes  • Congenital Heart Defects  • Alert me on articles by topic

Chris Feudtner, MD, PhD, MPH

Arch Pediatr Adolesc Med. 2008;162(9):854-857.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

What ethical challenges arise when, in an era like ours, the frequent arrival of new therapeutic interventions constantly transforms the status quo of health care, pushing forward the boundary of what is possible and, perhaps, desirable? Several of these challenges come into particular focus in 2 articles in this issue of Archives. Both articles scrutinize the treatment options offered to parents of infants with hypoplastic left heart syndrome (HLHS), and both reach resolute but differing opinions regarding whether palliative care should be routinely offered.While this debate involves data that are very specific to HLHS, data that have changed over time and likely vary across treatment centers, close examination of the arguments reveals more general issues about how complex clinical treatment decisions are—and should be—made.

INFORMED CONSENT AND CLINICIAN INTEGRITY

Two core concepts provide the foundation for our inquiry: informed consent and clinician integrity. Of these two, the doctrine of . . . [Full Text of this Article]

THE TASKS OF COMPLEX THERAPEUTIC DECISION MAKING

BALANCE IN THE ETHICS OF MEDICAL DECISION MAKING

AUTHOR INFORMATION